Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CD20 Antibody (9D637)

😃Good
Catalog No. TMAY-01444
Alias S7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1

Anti-CD20 Antibody (9D637) is a Mouse antibody targeting CD20. Anti-CD20 Antibody (9D637) can be used in WB,IHC-P,IP.

Anti-CD20 Antibody (9D637)

Anti-CD20 Antibody (9D637)

😃Good
Catalog No. TMAY-01444Alias S7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1
Anti-CD20 Antibody (9D637) is a Mouse antibody targeting CD20. Anti-CD20 Antibody (9D637) can be used in WB,IHC-P,IP.
Pack SizePriceAvailabilityQuantity
100 μL$199 7-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anti-CD20 Antibody (9D637) is a Mouse antibody targeting CD20. Anti-CD20 Antibody (9D637) can be used in WB,IHC-P,IP.
AliasS7, MS4A2, MS4A1, membrane-spanning 4-domains, subfamily A, member 1, LEU-16, CVID5, CD20, Bp35, B1
Ig Type
Monoclonal Mouse IgG1
Clone
9D637
Reactivity
Human
Verified Activity
1. Anti-CD20 mouse monoclonal antibody at 1:1000 dilution.

-Lane A: Raji Whole Cell lysate.

-Lysates/proteins at 30 μg per lane.

-Secondary

-Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution.

-Developed using the ECL technique.

-Performed under reducing conditions.

-Predicted band size:33 kDa.

-Observed band size:36 kDa.

2. Immunochemical staining of human CD20 in human tonsil with mouse monoclonal antibody at 1:200 dilution, formalin-fixed paraffin embedded sections.

3. Immunochemical staining of human CD20 in human lymphoma with mouse monoclonal antibody at 1:200 dilution, formalin-fixed paraffin embedded sections.

4. Anti-CD20 mouse monoclonal antibody at 1:500 dilution.

-Lane A: Raji Whole Cell Lysate.

-Lane B: CD20 konckout Raji Whole Cell lysate.

-Lysates/proteins at 10 μg per lane.

-Secondary

-Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution.

-Developed using the ECL technique.

-Performed under reducing conditions.

-Predicted band size:33 kDa.

-Observed band size:36 kDa.

5. CD20 was immunoprecipitated using:

-Lane A:0.5 mg Raji Whole Cell Lysate.

-4 µL anti-CD20 mouse monoclonal antibody and 60 μg of Immunomagnetic beads Protein A/G.

-Primary antibody:

-Anti-CD20 mouse monoclonal antibody, at 1:100 dilution.

-Secondary antibody:

-Rabbit Anti-Mouse IgG F(ab)2/HRP at 1/10000 dilution.

-Developed using the ECL technique.

-Performed under reducing conditions.

-Predicted band size: 33 kDa.

-Observed band size:37 kDa
Application
WB,IHC-P,IP
Recommended Dose
WB: 1:500-1:2000; IHC-P: 1:100-1:1000; IP: 1-5 μL/mg of lysate
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD20 / MS4A1 (rh CD20 / MS4A1; TMPY-02819; NP_068769.2; Glu213-Pro297). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundCD20 (membrane-spanning 4-domains, subfamily A, member 1), also known as MS4A1, is a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. CD20 / MS4A1 is expressed in all stages of B cell development except the first and last. CD20 / MS4A1 is present from pre-pre B cells through memory cells, but not on either pro-B cells or plasma cells. It is a B-lymphocyte surface molecule that plays a role in the development and differentiation of B-cells into plasma cells. CD20 / MS4A1may be involved in the regulation of B-cell activation and proliferation. Defects in CD20 / MS4A1 are the cause of immunodeficiency common variable type 5(CVID5). CVID5 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections, and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells are usually in the normal range but can be very low.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Human CD20 / MS4A1 Protein (TMPY-02819)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Anti-CD20 Antibody (9D637) | purchase Anti-CD20 Antibody (9D637) | Anti-CD20 Antibody (9D637) cost | order Anti-CD20 Antibody (9D637)